The combination of entecavir and peginterferon alfa-2a in HBeAg-positive immune-tolerant (IT) children and adolescents with chronic hepatitis B virus (HBV) Infection: Results of the HBRN pediatric IT trial.
HEPATOLOGY（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要